Advertisement
Advertisement
ETON
Eton Pharmaceutcials, Inc. Common Stock
58.45
USDSponsored
-1.45
-2.42%
Sep 04, 15:59 UTC -4
Closed
After-Market
58.13
-0.32
-0.54%
ETON Earnings Reports
Positive Surprise Ratio
ETON beat 13 of 29 last estimates.
45%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$39.64M
/$0.32
Implied change from Q2 26 (Revenue/ EPS)
+5.46%
/-8.57%
Implied change from Q3 25 (Revenue/ EPS)
+76.50%
/-557.14%
Eton Pharmaceutcials, Inc. Common Stock earnings per share and revenue
On Aug 13, 2026, ETON reported earnings of 0.35 USD per share (EPS) for Q2 26, beating the estimate of 0.10 USD, resulting in a 226.80% surprise. Revenue reached 37.59 million, compared to an expected 27.66 million, with a 35.89% difference. The market reacted with a +44.26% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of 0.32 USD, with revenue projected to reach 39.64 million USD, implying an decrease of -8.57% EPS, and increase of 5.46% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-Surprise
-
Anavex Life Sciences
Report Date
Aug 25, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Molecular Partners AG - ADR
Report Date
Aug 25, 2026 For Q2 26
Estimate
-Actual
-$0.35
Surprise
-
FAQ
What were Eton Pharmaceutcials, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Eton Pharmaceutcials, Inc. Common Stock reported EPS of $0.35, beating estimates by 226.8%, and revenue of $37.59M, 35.89% above expectations.
How did the market react to Eton Pharmaceutcials, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 44.26%, changed from $40.80 before the earnings release to $58.86 the day after.
When is Eton Pharmaceutcials, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Eton Pharmaceutcials, Inc. Common Stock's next earnings report?
Based on 4
analysts, Eton Pharmaceutcials, Inc. Common Stock is expected to report EPS of $0.32 and revenue of $39.64M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement